Intended for UK Healthcare Professionals. Prescribing Information and Adverse Events reporting can be accessed in the footer of the site.

Migraine Space

Practical management of migraine and comorbid depression and anxiety

Dr Sophie White and Elizabeth Shaw share real-world strategies to help you manage migraine patients with depression and anxiety

Practical management of migraine and comorbid depression and anxiety

Head Start 2025 Webinar

Dr Sophie White, Clinical Psychologist, and Elizabeth Shaw, Lead Headache Specialist Nurse, share practical insights into managing migraine alongside depression and anxiety - from spotting symptoms to approaching conversations with empathy and confidence. 

They outline how to use simple screening tools such as GAD-7 and PHQ-9 effectively, and, drawing on data from the UNITE study, explore the role of anti-CGRP therapies in patients with comorbid depression.1*

*AJOVY® (fremanezumab) is not indicated for the treatment of comorbid major depressive disorder

Resources

Education & Events Featured

Sleep Disorders and Headache

Dr Alexander Nesbitt provides an overview of sleep-related headache disorders

Education & Events

Cracking complex cases: complexities of comorbidities in headache

Complexities of comorbidities in headache with Dr David Moreno and Dr Maria Villar-Martinez

Education & Events

Understanding the burden of migraine on the NHS

Bethany Hill and Elizabeth Akinsanya discuss how migraine prevention can ease NHS pressure and improve outcomes.

Education & Events

Care closer to home – headache service redesign to bring care into the community

Anne-Marie Logan discusses headache service redesign to bring care into the community

Education & Events

Managing migraine patients’ unmet need today

Susie Lagrata and Claire Fisher deliver a nurse-led masterclass on unmet needs in migraine care

Education & Events

Migraine anxiety & depression cycle: CGRP inhibitors help break it?

Dr Giorgio Lambru discusses migraine anxiety and depression cycle

Education & Events

Behavioural change for migraine prevention

Professor Ivo Vlaev discusses the application of behavioural science in migraine prevention

References:

1. Lipton RB, et al. JAMA Neurol. 2025;82(6):560-9

Abbreviations:

CGRP, calcitonin gene-related peptide
GAD-7, generalised anxiety disorder-7
PHQ-9, patient health questionnaire-9

Date of Preparation: March 2026 | D: MIG-GB-00923 / T: MIG-GB-00982 / M: MIG-GB-00983
Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX